- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
La Jolla Pharmaceutical is a biotechnology business based in the US. La Jolla Pharmaceutical shares (LJPC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $6.22 – the same closing value as a week prior. La Jolla Pharmaceutical employs 61 staff and has a trailing 12-month revenue of around $46.5 million.
What's in this guide?
- LJPC shares summary
- Compare share dealing platforms
- Is LJPC stock a buy or sell?
- Stock performance over time
- Can I short LJPC shares?
- Are LJPC shares over-valued?
- La Jolla Pharmaceutical's financials
- How volatile are LJPC shares?
- Does La Jolla Pharmaceutical pay a dividend?
- Have LJPC shares ever split?
- Other common questions
Our top picks for where to buy La Jolla Pharmaceutical stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy La Jolla Pharmaceutical stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – LJPC. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy La Jolla Pharmaceutical stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
La Jolla Pharmaceutical stock price (NASDAQ: LJPC)
Use our graph to track the performance of LJPC stocks over time.La Jolla Pharmaceutical shares at a glance
Latest market close | $6.22 |
---|---|
52-week range | $0.00 - $0.00 |
50-day moving average | $5.11 |
200-day moving average | $4.46 |
Wall St. target price | $6.23 |
PE ratio | 47.8462 |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $0.13 |
Is it a good time to buy La Jolla Pharmaceutical stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
La Jolla Pharmaceutical price performance over time
Historical closes compared with the close of $6.22 from 2022-08-22
1 week (2024-10-06) | N/A |
---|---|
1 month (2024-09-13) | N/A |
3 months (2024-07-13) | N/A |
6 months (2024-04-13) | N/A |
1 year (2023-10-13) | N/A |
---|---|
2 years (2022-10-13) | N/A |
3 years (2021-10-15) | 57.07% |
5 years (2019-10-17) | 8.69 |
Is La Jolla Pharmaceutical stock undervalued or overvalued?
Valuing La Jolla Pharmaceutical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of La Jolla Pharmaceutical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
La Jolla Pharmaceutical's P/E ratio
La Jolla Pharmaceutical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 48x. In other words, La Jolla Pharmaceutical shares trade at around 48x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
La Jolla Pharmaceutical financials
Revenue TTM | $46.5 million |
---|---|
Gross profit TTM | $63.1 million |
Return on assets TTM | -1.52% |
Return on equity TTM | 0% |
Profit margin | 8.54% |
Book value | $-0.61 |
Market Capitalization | $155.1 million |
TTM: trailing 12 months
La Jolla Pharmaceutical share dividends
We're not expecting La Jolla Pharmaceutical to pay a dividend over the next 12 months.
Have La Jolla Pharmaceutical's shares ever split?
La Jolla Pharmaceutical's shares were split on a 1:50 basis on 13 January 2014. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your La Jolla Pharmaceutical shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for La Jolla Pharmaceutical shares which in turn could have impacted La Jolla Pharmaceutical's share price.
La Jolla Pharmaceutical share price volatility
Over the last 12 months, La Jolla Pharmaceutical's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while La Jolla Pharmaceutical's is 2.4079. This would suggest that La Jolla Pharmaceutical's shares are significantly more volatile than the average for this exchange and represent a higher risk.
La Jolla Pharmaceutical overview
La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The company has license agreement with Everest Medicines Limited to develop and commercialize XERAVA; and PAION AG to commercialize GIAPREZA and XERAVA. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts. As of August 22, 2022, La Jolla Pharmaceutical Company operates as a subsidiary of Innoviva, Inc.
Frequently asked questions
What percentage of La Jolla Pharmaceutical is owned by insiders or institutions?Currently 1.903% of La Jolla Pharmaceutical shares are held by insiders and 70.848% by institutions. How many people work for La Jolla Pharmaceutical?
Latest data suggests 61 work at La Jolla Pharmaceutical. When does the fiscal year end for La Jolla Pharmaceutical?
La Jolla Pharmaceutical's fiscal year ends in December. Where is La Jolla Pharmaceutical based?
La Jolla Pharmaceutical's address is: 201 Jones Road, Waltham, MA, United States, 02451 What is La Jolla Pharmaceutical's ISIN number?
La Jolla Pharmaceutical's international securities identification number is: US5034596040 What is La Jolla Pharmaceutical's CUSIP number?
La Jolla Pharmaceutical's Committee on Uniform Securities Identification Procedures number is: 503459604
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question